Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4results about How to "Not to damage" patented technology

Prevention of unpowered reverse rotation in compressors

InactiveUS20060222510A1prevent reversalrule out the possibilityFluid parameterOscillating piston enginesDrive motorAir conditioning
The shutdown of a compressor (10) installed in a refrigerant circuit (2) in air conditioning or refrigeration system is controlled so as to prevent unpowered reverse rotation of the compressor. Prior to terminating electric power to the compressor drive motor (24), the pressure within the system is relieved and substantially equalized across the compressor, thereby eliminating the possibility of unpowered reverse rotation of the compressor at shutdown. Pressure relief and equalization may be achieved by reducing the operating speed of the compressor to a low forward speed for a period of time prior to deenergizing the compressor drive motor. Pressure equalization may also be achieved by driving the compressor in reverse rotation prior to deenergizing the drive motor.
Owner:CARRIER CORP

Battery cell, battery, electrical device, and method and apparatus for manufacturing battery cell

Provided are a battery cell, a battery, an electrical apparatus, and a method and device for manufacturing a battery cell. The battery cell includes a case (110), an end cover (120), an electrode assembly (130) and a solder (140), the case (110) has an accommodating cavity (111) and an opening at one end; the end cover (120) is connected to the case (110); the electrode assembly (130) is provided in the accommodating cavity (111), the electrode assembly (130) has a first tab (131), and the first tab (131) faces the opening; the solder (140) is provided between the end cover (120) and the first tab (131) and connects the end cover (120) and the first tab (131); an insulating member (150) is also provided between the end cover (120) and the first tab (131), an insulating cavity (151) is provided on the insulating member (150), a feed port (152) is provided on one side of the insulating cavity (151), and the feed port (152) faces the solder (140).
Owner:CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED

Verschluss des linken vorhofohrs und freisetzungssystem dafür

A left atrial appendage (LAA) closure (1) and a system (6) for delivering the LAA closure are disclosed. The LAA closure (1) includes supporting struts (11), wherein the supporting struts (11) are distributed peripherally around a first hub (10) and extend outward, the supporting strut (11) bifurcates at a first position (110) into a left branch (111) and a right branch (112). The left branch (111) of each supporting strut (11) and the right branch (112) of an adjacent supporting strut join each other at a second position (113) and extend distally to form a distal end. The LAA closure further includes a supporting rod (12) between adjacent supporting struts (11) which ensures stability, absence of irregular deformation and lateral slippage, of the LAA closure (1). With the supporting rods (12) between the adjacent supporting struts (11), the LAA closure (1) forms a dense mesh which imparts high overall strength of the LAA closure (1).
Owner:SHANGHAI MICROPORT CARDIOADVENT CO LTD

Pharmaceutical preparation for low-temperature thermotherapy, and preparation method therefor and use thereof

The present invention claims an application of a CNSI-Fe compound preparation in preparing a tumor hyperthermia drug used in conjunction with near-infrared light. When the compound preparation is used for low-temperature hyperthermia, the administration dosage can be decreased so as to reduce the occurrence of adverse reactions; the hyperthermia using the compound preparation has a low temperature, so that the surrounding normal tissues are not liable to be damaged, and the adverse reactions during the hyperthermia using carbon nanoparticles can also be reduced. Moreover, it is further proved that the CNSI-Fe compound preparation and the near-infrared irradiation are synergic. Based on the means and technical effects of low-temperature hyperthermia, the present invention has extensive clinical significance.
Owner:SICHUAN ENRAY PHARM TECH CO LTD